about
Molecular characterization of pneumococcal isolates from pets and laboratory animals.Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants.Factors that cause trimethoprim resistance in Streptococcus pyogenes.Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid.Variable recombination dynamics during the emergence, transmission and 'disarming' of a multidrug-resistant pneumococcal cloneEvidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.Temporal Variations among Invasive Pneumococcal Disease Serotypes in Children and Adults in Germany (1992-2008).Detection of large numbers of pneumococcal virulence genes in streptococci of the mitis group.Relationship between the original multiply resistant South African isolates of Streptococcus pneumoniae from 1977 to 1978 and contemporary international resistant clones.Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults.Epidemiology of serotype 19A isolates from invasive pneumococcal disease in German childrenSeven-year surveillance of emm types of pediatric Group A streptococcal pharyngitis isolates in Western Greece.Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in GermanyTravel-related Streptococcal toxic shock syndrome caused by emm type 78 Streptococcus pyogenes.Increase of serotypes 15A and 23B in IPD in Germany in the PCV13 vaccination era.Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany.Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in GermanyAntimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.Streptococcus pneumoniae as an agent of urinary tract infections - a laboratory experience from 2010 to 2014 and further characterization of strains.Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in GermanyWhole Genome Sequencing of 39 Invasive Streptococcus pneumoniae Sequence Type 199 Isolates Revealed Switches from Serotype 19A to 15BClinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.Polyclonal population structure of Streptococcus pneumoniae isolates in Spain carrying mef and mef plus erm(B).Virulence factors of Streptococcus pyogenes strains from women in peri-labor with invasive infections.Severe soft tissue infection caused by a non-beta-hemolytic Streptococcus pyogenes strain harboring a premature stop mutation in the sagC gene.Identification of Streptococcus suis Meningitis through Population-Based Surveillance, Togo, 2010-2014.Discovery of Streptococcus pneumoniae serotype 6 variants with glycosyltransferases synthesizing two differing repeating units.Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in EuropePneumococcal polysaccharide vaccination for adults: new perspectives for Europe.A cohort study of the impact and acquisition of naspharyngeal carriage of Streptococcus pneumoniae during the Hajj.Serotype distribution of invasive pneumococcal disease during the first 60 days of life.Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule.Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.Viridans and bovis group streptococci that cause infective endocarditis in two regions with contrasting epidemiology.Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination.Incidence of invasive pneumococcal disease in 5-15 year old children with and without comorbidities in Germany after the introduction of PCV13: Implications for vaccinating children with comorbidities.Antibiotic susceptibility rates of invasive pneumococci before and after the introduction of pneumococcal conjugate vaccination in Germany.Impact of the Hajj on pneumococcal transmission.Recent trends in epidemiology of invasive pneumococcal disease in Poland.
P50
Q33518521-FF26B987-B22E-414D-AA03-D48CC64AC975Q33525194-87C91231-C7BE-42C2-A4D2-722DDB6E65D7Q33622858-F6699148-E5EE-428E-966E-452428AFA8EDQ33627288-0508A88D-C9AF-46FD-BCD3-989726F324B9Q33891667-2936EB26-76B7-4213-B9AE-BB680CDE9C61Q34007220-8B88FA6E-E250-41EB-81DE-FFA68F2165CAQ34021871-DE602747-2467-4806-9CF9-4AAB3B1C260BQ34046452-A6A4468D-D8B9-4F3C-92E1-B506AA141304Q34231713-079EF059-BEC7-4740-893C-9A0788FE26CEQ34407129-8D91B45F-A9F6-44B8-A290-45DA252C13FDQ34533937-EE599475-CFBB-43C9-8DD0-A8226363DA5FQ34577705-BCA93C58-E4FB-43E2-98A3-A119AF2C824EQ34971503-EB53E0BC-01BD-4CBE-929D-DBFCDC0C9F49Q35105368-5642DA60-C0D6-433E-BA62-488EA2624300Q35139843-2403B729-C446-4A48-AAED-5DB9FCB6BBF4Q35583895-3B573EFF-B03E-425E-BD7D-AA11A0320B89Q35679787-77426A3E-DD42-4176-B091-FDA59AD5F736Q35759018-AC3CB28E-E86D-47DF-AF39-3EE59DF41391Q36028869-47FF388B-7D76-4C99-B26A-E4D2BE1A37ADQ36061469-AF11AAE8-EE62-4D8F-A0FF-87A237DDC4A2Q36104219-FC47F493-78F3-44CE-93B7-42835757B697Q36238637-FCD27538-1E0E-42F9-9818-5B5D050FCC59Q36423634-6871A983-C669-47B9-8C30-F52AD24F2A52Q36703034-E08546EF-0A7A-40EC-96DB-907770E05E75Q36823700-89FDC98C-86AD-4C68-A9FC-F1614CE68644Q37026498-529195C7-2A8E-45E2-ACF6-F7B12B16E0EAQ37031535-20B1D44C-F11A-4EED-BF65-ABA4E5581655Q37151037-9E466272-C7FD-47EB-829D-AFD0CA6B0260Q37156883-880946C0-D1ED-41D0-B97B-053D7AA2F31FQ37910264-86DD8E41-B9B4-4E9B-892F-E7A736F8DB4BQ39758643-91280174-CCA7-468D-9DF3-2117E01E7495Q39872951-5FE6C0F2-7085-4D62-921D-A6DF11B16A08Q39964894-77526723-46C4-4C9A-9BDB-F7439D8D5998Q39983387-BE733C64-3CDD-4AFC-AA42-C0E7CEB3E574Q40228513-E16CBF9F-2A24-46F8-B9C3-3AC134C4CC76Q40918160-E4C82F08-507D-42DB-8A81-E5300ACD6B7BQ40923267-60EBB0C8-8250-498A-932E-966EC3EF20CDQ41023439-E66F7DAE-DEC4-46A7-AA66-883493115E42Q41512654-7240FEE3-BAA9-4DE1-B0DF-CE92BB897AAFQ41617785-A5B14DF1-2B7A-4639-AED7-CF8A7DDF97CB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark van der Linden
@ast
Mark van der Linden
@en
Mark van der Linden
@es
Mark van der Linden
@nl
Mark van der Linden
@sl
type
label
Mark van der Linden
@ast
Mark van der Linden
@en
Mark van der Linden
@es
Mark van der Linden
@nl
Mark van der Linden
@sl
prefLabel
Mark van der Linden
@ast
Mark van der Linden
@en
Mark van der Linden
@es
Mark van der Linden
@nl
Mark van der Linden
@sl
P1053
B-9305-2009
P106
P21
P31
P3829
P496
0000-0002-6574-4313